Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bioo Scientific Create New Therapeutics Division
Bioo Scientific has launched a new division, Bioo Therapeutics, to leverage their drug delivery vehicles and experience in antibody and small molecule research. The company seeks to use
Bioo Scientific has launched a new division, Bioo Therapeutics, to leverage their drug delivery vehicles and experience in antibody and small molecule research. The company seeks to use
Nutra Pharma has reported that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing
BioAlliance has presented its results on a new oral chemotherapy nanoparticle formulation at the AAPS (American Association of Pharmaceutical Scientists) annual meeting in Los Angeles. The company claims,
Novartis has put a halt on its research and development venture in India, said Daniel Vasella, CEO of the company. This action is reportedly a result of the
Trimurthi Drugs and Pharmaceuticals has announced that it has received NS-EN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from ‘kvalitet veritas quality assurance’,
FDA has acknowledged receipt of Sol-Gel Technologies’ (Sol-Gel) Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. The IND allows Sol-Gel to initiate
GlaxoSmithKline (GSK) today announced that the FDA has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine. The approval of the sBLA,
Belgium’s regulatory agency, the AFMPS has approved NextPharma Technologies’ new Sterile Product Development Centre (SPDC) in Braine l’Alleud. NextPharma had signed its first contract in April and will
DotCode, a rectangular matrix symbology, was published by AIM, the international association focusing on bar codes, RFID and enterprise mobile computing. Reportedly, the DotCode is suitable for machine-readable
InVitria has expanded its manufacturing capacity to meet commercial demands for Lysobac. Lysobac is an animal free reagent for bacterial fermentation. InVitria claims, Lysobac is a high potency,